RBX1 and acute myeloid leukemia: Similarly, over-expression of UBA3, UBE2M and RBX1 was associated with worse survival of AML patients (P<0.001, log-rank test, Figure 1I–K), which was an independent prognostic factor for OS in AML (P<0.01).